NASDAQ:AKTS

Akoustis Technologies Stock Forecast, Price & News

$9.03
-0.32 (-3.42 %)
(As of 07/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.75
$9.30
50-Day Range
$9.01
$11.24
52-Week Range
$7.31
$19.15
Volume455,919 shs
Average Volume696,419 shs
Market Capitalization$454.88 million
P/E RatioN/A
Dividend YieldN/A
Beta1.38
30 days | 90 days | 365 days | Advanced Chart
Receive AKTS News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoustis Technologies and its competitors with MarketBeat's FREE daily newsletter.


Akoustis Technologies logo

About Akoustis Technologies

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industry in the United States. It operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services; and semiconductor wafer-manufacturing and microelectromechanical systems foundry services. The RF Filters segment consists of amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, military and defense applications. The company was incorporated in 2013 and is headquartered in Huntersville, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.82 out of 5 stars

Computer And Technology Sector

406th out of 1,651 stocks

Telephone & Telegraph Apparatus Industry

7th out of 39 stocks

Analyst Opinion: 3.5Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

Is Akoustis Technologies a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Akoustis Technologies stock.
View analyst ratings for Akoustis Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than Akoustis Technologies?

Wall Street analysts have given Akoustis Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Akoustis Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Akoustis Technologies' next earnings date?

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Monday, August 23rd 2021.
View our earnings forecast for Akoustis Technologies
.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies, Inc. (NASDAQ:AKTS) announced its earnings results on Sunday, May, 2nd. The technology company reported ($0.22) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.01. The technology company earned $2.52 million during the quarter, compared to analyst estimates of $2.25 million. Akoustis Technologies had a negative net margin of 913.86% and a negative trailing twelve-month return on equity of 51.94%. The firm's revenue was up 594.2% on a year-over-year basis.
View Akoustis Technologies' earnings history
.

How has Akoustis Technologies' stock been impacted by COVID-19?

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AKTS shares have increased by 70.1% and is now trading at $9.03.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for AKTS?

5 Wall Street analysts have issued twelve-month price objectives for Akoustis Technologies' stock. Their forecasts range from $14.00 to $20.00. On average, they anticipate Akoustis Technologies' stock price to reach $17.40 in the next twelve months. This suggests a possible upside of 92.7% from the stock's current price.
View analysts' price targets for Akoustis Technologies
or view top-rated stocks among Wall Street analysts.

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the following people:

Who are some of Akoustis Technologies' key competitors?

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Taylor Frigon Capital Management LLC (0.98%) and SkyOak Wealth LLC (0.12%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies
.

Which institutional investors are selling Akoustis Technologies stock?

AKTS stock was sold by a variety of institutional investors in the last quarter, including Taylor Frigon Capital Management LLC, and SkyOak Wealth LLC. Company insiders that have sold Akoustis Technologies company stock in the last year include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars, and Suzanne B Rudy.
View insider buying and selling activity for Akoustis Technologies
or view top insider-selling stocks.

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $9.03.

How much money does Akoustis Technologies make?

Akoustis Technologies has a market capitalization of $454.88 million and generates $1.79 million in revenue each year. The technology company earns $-36,140,000.00 in net income (profit) each year or ($0.86) on an earnings per share basis.

How many employees does Akoustis Technologies have?

Akoustis Technologies employs 95 workers across the globe.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is www.akoustis.com.

Where are Akoustis Technologies' headquarters?

Akoustis Technologies is headquartered at 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.